Inflammatory vaginitis associated with long-term rituximab treatment in a patient with multiple sclerosis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt


  • Fulltext

    Forlagets udgivne version, 171 KB, PDF-dokument

We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment for multiple sclerosis in the absence of any other systemic disease or underlying malignancy. More studies are needed to characterise the incidence of inflammatory vaginitis among women on long-term rituximab therapy.

TidsskriftBMJ Case Reports
Udgave nummer11
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for- profit sectors.

Publisher Copyright:
© BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

ID: 329305424